Results 121 to 130 of about 108,965 (216)

A lytic enzyme induced by lysozyme mutant colitis phage and from a cloned gene

, 1987
The lysozyme mutant colitis phage induced a lytic enzyme 21 min after infection of the host, Escherichia coli B. Unlike the wild phage-induced lysozyme, this lytic enzyme acted on E. coli cells but not on Micrococcus lysodeikticus cells.
Gupta, Anita, Padayatty, JD
core  

Isolation and Characterization of Lytic Coliphages from Sewage Water

, 2017
The goal of this study was to isolate and characterize phages that might be used in transport and treatment of potential E.coli pathogen in water sources.
PS Harikumar, S. Murugan, S Murugan, P.S. Harikumar, P.U. Megha, PU Megha   +5 more
core   +1 more source

Genomic analysis and characterization of lytic bacteriophages that target antimicrobial resistant Escherichia coli in Addis Ababa, Ethiopia

Heliyon
The emergence of antibiotic resistance in E. coli strains has sparked a fervent investigation of alternative therapies, such as the use of lytic bacteriophages.
Tamirat Salile Sada, Dawit Hailu Alemayehu, Kalkidan Melaku Tafese, Tesfaye Sisay Tessema   +3 more
doaj   +1 more source

Lytic bacteriophages induce the secretion of antiviral and proinflammatory cytokines from human respiratory epithelial cells.

PLoS Biology
Phage therapy is a therapeutic approach to treat multidrug-resistant (MDR) infections that employs lytic bacteriophages (phages) to eliminate bacteria. Despite the abundant evidence for its success as an antimicrobial in Eastern Europe, there is scarce ...
Paula F Zamora, Thomas G Reidy, Catherine R Armbruster, Ming Sun, Daria Van Tyne, Paul E Turner, Jonathan L Koff, Jennifer M Bomberger   +7 more
doaj   +1 more source

Obtaining a lytic bacteriophage suitable for use in phage therapy against Clostridioides difficile infection [PDF]

Clostridioides difficile is the leading cause of hospital-acquired and antibiotic-associated diarrhoea in the developed world. More effective countermeasures are required.
Kerr, Sarah
core   +2 more sources

A new Kayvirus vB_SauM-MUHD-1 combats Methicillin-resistant Staphylococcus aureus wound infections

Applied Microbiology and Biotechnology
Methicillin-resistant Staphylococcus aureus (MRSA), a leading cause of chronic and post-surgical wound infections, is a hard-to-treat pathogen. In this study, we isolated and characterized a lytic MRSA bacteriophage, vB_SauM-MUHD-1, and evaluated its ...
Maha Kabil, Noha T. Abou El-Khier, Wafaa Mowafy, Abeer M. Abd El-Aziz, Mohamed Abdelmoteleb   +4 more
doaj   +1 more source

Phage Therapy and Phage Engineering technologies for tackling Antibiotic-Resistance in Bacterial Infections

openIn recent years, the escalating crisis of antibiotic resistance has spurred the search for alternative antimicrobial strategies, with bacteriophage therapy emerging as a promising candidate.
ORLANDI, SIMONE
core  

ALTERNATIVES TO ANTIBIOTICS: PHAGE LYTIC ENZYMES AND PHAGE THERAPY [PDF]

Bulletin of Russian State Medical University, 2018
openaire   +1 more source

Insight into the lytic cassette of the lactococcal phage TP712

, 2019
Peer ...
Escobedo, Susana, Roces, Clara, Wegmann, Udo, García Suárez, María Pilar, Rodríguez González, Ana, Martínez Fernández, Beatriz   +5 more
openaire   +1 more source

Phage-based deodorant: isolation and characterisation of a bacteriophages targeting odour-generating Staphylococcus species and expression of recombinant phage endolysins

Human axillary malodour arises when secretions from sebaceous, eccrine, and apocrine glands are biotransformed by skin bacteria into volatile fatty acids, thioalcohols, and steroid derivatives. Broad-spectrum preservatives used in deodorants can suppress
Abdullah A. Alahmadi (24236626)
core   +1 more source